Halma plc 25.6% Potential Decrease Indicated by JP Morgan Cazenove

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Halma plc with EPIC/TICKER (LON:HLMA) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘UNDERWEIGHT’ this morning by analysts at JP Morgan Cazenove. Halma plc are listed in the Industrials sector within UK Main Market. JP Morgan Cazenove have set their target price at 1370 GBX on its stock. This now indicates the analyst believes there is a potential downside of -25.6% from the opening price of 1842.5 GBX. Over the last 30 and 90 trading days the company share price has decreased 302.5 points and decreased 329.5 points respectively. The 52 week high for the share price is currently at 2261 GBX while the 52 week low for the share price is 1641.48 GBX.

Halma plc has a 50 day moving average of 2,106.02 GBX and the 200 Day Moving Average price is recorded at 2,038.22. There are currently 449,309,833 shares in issue with the average daily volume traded being 1,522,788. Market capitalisation for LON:HLMA is £6,826,022,494 GBP.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    Halma plc (LON:HLMA) reports strong half-year results, announcing a 7% interim dividend increase, boosting shareholder returns in 2024.
    Halma Plc acquires Lamidey Noury Medical, expanding its healthcare portfolio with advanced electrosurgical devices for minimally invasive procedures.
    Halma plc (LON:HLMA) has released its full year results for the year ending 31 March 2024. Explore the financial details and dividend information here.
    Halma plc (LON: HLMA) releases its trading update for the financial year, showing strong growth and strategic investments. Full year results expected on 13 June 2024.

      Search

      Search